2019
DOI: 10.1016/j.jpeds.2019.07.011
|View full text |Cite
|
Sign up to set email alerts
|

Lead screening update from the US Preventive Services Task Force

Abstract: Question What is the level of evidence for lead screening in asymptomatic children? Design Systematic review.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 1 publication
0
2
0
Order By: Relevance
“…1,20 In September 2019, the US Preventive Services Task Force concluded that questionnaires and other clinical tools are unable to identify asymptomatic children who have elevated serum lead levels, based on a systematic review that included 24 previous studies. 21,22 Our data continue to question the utility of such screening tools, with less than 1% of patients in this study having elevated serum lead levels while the majority of these patients met high-risk criteria on local risk assessment tools. Furthermore, the data suggest that these screening tools are leading to overtesting of asymptomatic patients, which may lead to overutilization of clinical resources and patient harm.…”
Section: Discussionmentioning
confidence: 70%
See 1 more Smart Citation
“…1,20 In September 2019, the US Preventive Services Task Force concluded that questionnaires and other clinical tools are unable to identify asymptomatic children who have elevated serum lead levels, based on a systematic review that included 24 previous studies. 21,22 Our data continue to question the utility of such screening tools, with less than 1% of patients in this study having elevated serum lead levels while the majority of these patients met high-risk criteria on local risk assessment tools. Furthermore, the data suggest that these screening tools are leading to overtesting of asymptomatic patients, which may lead to overutilization of clinical resources and patient harm.…”
Section: Discussionmentioning
confidence: 70%
“…19 Similar questionnaires developed to screen for lead exposure have been implemented at many pediatric clinics; however, studies have shown that these tools may not accurately identify a child’s risk of lead exposure. 1,20-22 Additionally, the implementation of screening tools in the primary care setting requires parental input as well as physician buy-in, training, and time, making implementation and application challenging. 23…”
Section: Introductionmentioning
confidence: 99%
“…Currently, the U.S. Preventive Services Task Force concludes that the available evidence is insufficient to assess the benefits and harms of screening for elevated blood lead levels in asymptomatic children, and the American Academy of Family Physicians recommends against universal lead testing of asymptomatic children ages 1 to 5 years [56]. However, the results of our study may call these recommendations into question and suggest adequate blood lead testing remains vital to uncovering and eliminating lead exposure pathways, as the measurable impact of proximity to airports on children's BLLs in our study is not likely to produce obvious symptoms [57,58].…”
Section: Discussionmentioning
confidence: 86%